Vimarsana
Biggest News Aggregation in the World

Millipore Sigma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Millipore Sigma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Millipore Sigma Today - Breaking & Trending Today

Antisense oligonucleotide therapeutic approach for Timothy syndrome - Vimarsana News

Antisense oligonucleotide therapeutic approach for Timothy syndrome

Timothy syndrome (TS) is a severe, multisystem disorder characterized by autism, epilepsy, long-QT syndrome and other neuropsychiatric conditions1. TS type 1 (TS1) is caused by a gain-of-function variant in the alternatively spliced and developmentally enriched CACNA1C exon 8A, as opposed to its counterpart exon 8. We previously uncovered several phenotypes in neurons derived from patients with TS1, including delayed channel inactivation, prolonged depolarization-induced calcium rise, impaired interneuron migration, activity-dependent dendrite retraction and an unanticipated ...

Source: nature.com
International Swine Viral Disease Conference marks 20 years - Vimarsana News

International Swine Viral Disease Conference marks 20 years

Dee honored for distinguished research, service to U.S. pork industry; Sundberg for his outstanding leadership, dedication to swine health.

MilliporeSigma and ACD/Labs in collaboration for ChemTwins platform - Vimarsana News

MilliporeSigma and ACD/Labs in collaboration for ChemTwins platform

Informatics software developer supporting R&D, ACD/Labs, has formed a collaboration with MilliporeSigma, the US and Canada Life Science business of Merck KGaA.

Drug Formulation Industry Aims for a Target of US$2.87 Trillion by 2032-FMI Projection - Vimarsana News

Drug Formulation Industry Aims for a Target of US$2.87 Trillion by 2032-FMI Projection

Drug Formulation IndustryFrom 2022 to 2032, the demand for drug formulation industry size is expected to rise at a compound annual growth rate (CAGR) of 5.6%. By 2022, the pharmaceutical formulations market was valued at approximately US$ 1.58 trillion, and by 2032, it is anticipated to grow to US$ 2.87 trillion. Or...

AMA: 2023 first-half earnings and Third-quarter revenues -October 31, 2023 at 04:21 am EDT - Vimarsana News

AMA: 2023 first-half earnings and Third-quarter revenues -October 31, 2023 at 04:21 am EDT

Press release Rennes, France -October31st, 2023 at 8:00 AM 2023 half-year earnings Third quarter revenue ...